Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New SEC filing - Confidential treatment order
UNITED STATES SECURITIES AND EXCHANGE COMMISSION February 14, 2013 ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934 Patriot Scientific Corporation File No. 000-22182- CF#28616 _____________________ Patriot Scientific Corporation submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 8-K filed on July 17, 2012, as amended on February 4, 2013. Based on representations by Patriot Scientific Corporation that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified: Exhibit 10.7 Exhibit 10.8 Exhibit 10.9 through July 17, 2017 through July 17, 2017 through July 17, 2017 For the Commission, by the Division of Corporation Finance, pursuant to delegated authority: Maryse Mills-Apenteng Special Counsel --> http://www.sec.gov/Archives/edgar/data/836564/999999999713000966/filename1.pdf
Share
New Message
Please login to post a reply